Meeting
2017 ASCO Annual Meeting
Chemotherapy induced nausea and vomiting in breast cancer treated with antiemetic prophylaxis as recommended by the ASCO antiemesis guidelines.
Authors
Ronda Copher
Eisai Co., Ltd., Woodcliff Lake, NJ
Russell L. Knoth , Glenn Magee , Soamnauth Misir , Ali McBride , Ronda Copher
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Patient and Survivor Care
Track
Patient and Survivor Care
Sub Track
Palliative Care and Symptom Management
Citation
J Clin Oncol 35, 2017 (suppl; abstr 10109)
DOI
10.1200/JCO.2017.35.15_suppl.10109
Abstract #
10109
Poster Bd #
98
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Physician concordance with update to ASCO guidelines for antiemetic use with carboplatin AUC ≥ 4.
First Author: Rudolph M. Navari
Poster
2020 ASCO Virtual Scientific Program
Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting (CINV): Results of the Nausea/Emesis Registry in Oncology (NERO).
First Author: Matti S. Aapro
Poster
2020 ASCO Virtual Scientific Program
Antiemetic prophylaxis with NEPA: Final results of the German AKYPRO study.
First Author: Joerg Peter Schilling
Poster
2017 Palliative and Supportive Care in Oncology Symposium
Comparison of hydration events in patients (pts) receiving highly (HEC) or moderately (MEC) emetogenic chemotherapy treated with granisetron extended-release subcutaneous (GERSC) or palonosetron (PALO).
First Author: Jeffrey Vacirca